Related references
Note: Only part of the references are listed.Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
Ajinkya Pawar et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options
Gabriela Barcenas-Morales et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses
Sarah Spencer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Andrew I. Rutherford et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Role of C-Reactive Protein at Sites of Inflammation and Infection
Nicola R. Sproston et al.
FRONTIERS IN IMMUNOLOGY (2018)
A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis
Tobias Schwerd et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
Ashitha L. Vijayan et al.
JOURNAL OF INTENSIVE CARE (2017)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections
Toshihiro Nanki et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis
Toshihisa Kojima et al.
MODERN RHEUMATOLOGY (2013)
Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
Norihiro Nishimoto et al.
MODERN RHEUMATOLOGY (2010)
The hyper-IgE syndromes
Alexandra F. Freeman et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Recurrent Staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6
Anne Puel et al.
JOURNAL OF IMMUNOLOGY (2008)
High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors
P Galle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Share Paper
